Related references
Note: Only part of the references are listed.Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins
Shan Chung et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
Algirdas Grevys et al.
NATURE COMMUNICATIONS (2018)
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms
Claudia A. Castro Jaramillo et al.
MABS (2017)
Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology
Kathi Williams et al.
BIOANALYSIS (2017)
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+early breast cancer
Angelica L. Quartino et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Projecting human pharmacokinetics of monoclonal antibodies from nonclinical data: comparative evaluation of prediction approaches in early drug development
Jing Wang et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2016)
Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous manual syringe injection or intravenously in women with HER2-positive early breast cancer
Angelica L. Quartino et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins
Fabian Higel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
Lindsay B. Avery et al.
MABS (2016)
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Daniela Bumbaca Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
Michal Pyzik et al.
JOURNAL OF IMMUNOLOGY (2015)
Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn
Tianlei Ying et al.
MABS (2015)
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan et al.
MABS (2015)
A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life
Colby A. Souders et al.
MABS (2015)
Targeting FcRn for the modulation of antibody dynamics
E. Sally Ward et al.
MOLECULAR IMMUNOLOGY (2015)
Quantitative cumulative biodistribution of antibodies in mice
Victor Yip et al.
MABS (2014)
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
Bing Li et al.
MABS (2014)
In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
Vikas K. Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Physiological Roles of Asialoglycoprotein Receptors (ASGPRs) Variants and Recent Advances in Hepatic-Targeted Delivery of Therapeutic Molecules Via ASGPRs
Jing Hu et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Brian Gurbaxani et al.
MOLECULAR IMMUNOLOGY (2013)
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K. Leabman et al.
MABS (2013)
Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies
Tilman Schlothauer et al.
MABS (2013)
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei et al.
PLOS ONE (2013)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
Josef Singer et al.
MOLECULAR IMMUNOLOGY (2012)
Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies
Deborah L. Mortensen et al.
MABS (2012)
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hoetzel et al.
MABS (2012)
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans
Marcella Yu et al.
MABS (2012)
Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions
Jonathan T. Sockolosky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
Weirong Wang et al.
DRUG METABOLISM AND DISPOSITION (2011)
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4
Daniela Bumbaca et al.
MABS (2011)
Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data What have we learned?
Rong Deng et al.
MABS (2011)
High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
Jin Hee Kim et al.
PLOS ONE (2011)
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
C. Andrew Boswell et al.
BIOCONJUGATE CHEMISTRY (2010)
Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
Rong Deng et al.
DRUG METABOLISM AND DISPOSITION (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Reduced elimination of IgG antibodies by engineering the variable region
T. Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity
Salit Tzaban et al.
JOURNAL OF CELL BIOLOGY (2009)
Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG
Menaka Sarav et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Evidence for an Asialoglycoprotein Receptor on Nonparenchymal Cells for O-Linked Glycoproteins
Eric G. Stefanich et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
Nancy A. Goebl et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Clinical pharmacokinetics and use of infliximab
Ulrich Klotz et al.
CLINICAL PHARMACOKINETICS (2007)
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor
Devin B. Tesar et al.
TRAFFIC (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
CM Ng et al.
PHARMACEUTICAL RESEARCH (2005)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
MC Franklin et al.
CANCER CELL (2004)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human β2-microglobulin
SM Claypool et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mannose receptor-mediated regulation of serum glycoprotein homeostasis
SJ Lee et al.
SCIENCE (2002)
Transcytosis and catabolism of antibody
V Ghetie et al.
IMMUNOLOGIC RESEARCH (2002)
Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells
F Antohe et al.
HUMAN IMMUNOLOGY (2001)
In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure
A Wright et al.
GLYCOBIOLOGY (2000)
Share Paper
